Advertisement
Canada markets closed
  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • Bitcoin CAD

    87,343.22
    -25.09 (-0.03%)
     
  • CMC Crypto 200

    1,367.90
    +55.27 (+4.21%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     
  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Walgreens sells some AmerisourceBergen shares for $694 million

FILE PHOTO: Walgreens brand Allergy Nasal Spray, owned by the Walgreens Boots Alliance, Inc., is seen for sale in Manhattan, New York City

(Reuters) - Walgreens Boots Alliance, one of the largest U.S. pharmacies, said on Thursday it has sold some of its shares in drug distributor AmerisourceBergen Corp for $694 million and will primarily use the proceeds to pay down debt.

AmerisourceBergen will repurchase about $50 million of its common stock from Walgreens in this transaction, the U.S. drugstore chain said, adding that its ownership of AmerisourceBergen's common stock would remain at 17%.

The Deerfield, Illinois-based company sold AmerisourceBergen shares for $1 billion last December, cutting its ownership from 20%.

The share sale has no impact on the long-term partnership between the two companies, Walgreens said.

(Reporting by Rishabh Jaiswal in Bengaluru; Editing by Sherry Jacob-Phillips)